2021-08-31 08:00
Significant events during the first quarter Significant events after the end of the period Audiocast: When: 2 September 2021 at 10:00 AM CET Where: https://tv.streamfabriken.com/biovica-international-q1-2021-2022 Phone numbers: SE: +46850558365, DK: +4578150108...
2021-06-17 08:00
Preparations for the launch of DiviTum®TKa
2021-03-18 08:00
FDA resumes review of DiviTum®TKa submission
2020-12-03 08:00
Convincing study results and application submitted to the FDA - commercialization just around the corner
2020-08-27 08:00
Clinical validation completed, work with the FDA submission in the final phase
2020-06-05 08:00
Preparations for the launch of DiviTum® have started
2020-03-12 08:00
Period: May-January 2019/2020
2019-12-05 08:00
“The results from two additional studies with DiviTum® will be presented at San Antonio Breast Cancer Symposium, the world's largest scientific conference on breast cancer”.
- Anders Rylander, CEO of Biovica
2019-08-29 08:00
Significant events during the first quarter Significant events after the end of the period CEO’s comments Commercialization of DiviTum® for breast cancer During the first quarter of the new financial year, we achieved several important milestones in...
2019-06-14 08:00
SEK thousands Q4 18/19 Q4 17/18 May-April 18/19 May-April 17/18
Net sales 1,715 1,433 ...
>4,500
Numbers of patients in studies
28
Publications
32
Pharma Projects